Cargando...
Assessment of the Chemosensitizing Activity of TAT-RasGAP(317-326) in Childhood Cancers
Although current anti-cancer protocols are reasonably effective, treatment-associated long-term side effects, induced by lack of specificity of the anti-cancer procedures, remain a challenging problem in pediatric oncology. TAT-RasGAP(317-326) is a RasGAP-derived cell-permeable peptide that acts as...
Guardado en:
| Publicado en: | PLoS One |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Public Library of Science
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4380404/ https://ncbi.nlm.nih.gov/pubmed/25826368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0120487 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|